Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 July 2020 | Story Andre Damons | Photo UFS photo archive
Prof Anthony Turton from the Centre for Environmental Management at the University of the Free State (UFS).

Since a South African team associated with the University of the Free State (UFS) became the first to isolate the SARS-CoV-2 virus from wastewater and developed a viable virus risk forensic service, there has been interest in this technology from a range of role players in North America, Africa, the Middle East, and Southeast Asia, to the South African government.

Prof Anthony Turton from the Centre for Environmental Management at the UFS says contact has been made with two separate scientific teams working in South Africa – one in the Western Cape associated with the Department of Health, and one coordinated by the Water Research Commission reporting to the Department of Water and Sanitation (DWS) – both of which are developing next-generation science. 

Prof Turton says the team has also presented a formal report to the DWS to show that first-generation science is quite capable of generating accurate data that is of great value to planners by feeding into national decision-making bodies.  

A proud achievement 
“As the person who conceptualised this service, I am very proud to be a South African citizen. My background is in national security, so it was that skill set which I applied to the problem when I asked the question – how can we provide the best available information in the shortest possible time, in the face of high risk and growing uncertainty, using the best available technology? This is only possible when one is trained in the intelligence sciences. Intelligence is about converting raw data, often from contested sources, into actionable bits of information with a defined level of certainty.” 
“However, the truly remarkable portion is the team that we rapidly assembled. By hand-picking the right kind of people for the team, we could unlock the power of synergy where 1 + 1 becomes 3. We, as South Africans, have developed a world first, and this is something we can collectively be deeply proud of. This is a proudly South African achievement, not an individual achievement. The benefits belong to society, because even when I was at the CSIR, I championed the notion of ‘science in the service of society’, and here we have another example,” says Prof Turton.

Using available technology
With the 824 wastewater treatment works (WWTW) in the country, the DWS can rapidly deploy this technology to any existing area of concern if they see value in it.  “At present, government is waiting for second-generation science to become available, but that is probably 24 months away at best. In the interim, a crisis is unfolding in the present, and first-generation science is clearly capable of providing sufficiently accurate information to assist in decision-making around the deployment of increasingly scarce resources.”

“DWS used similar technology in the cholera crisis a while back, so they are aware of the benefits. From a society perspective, the question is whether government must wait for the second-generation science to emerge before using the technology, even though first-generation technology can provide an important part of the missing data as explained above. This is what the foreign entities have grasped.”

According to Prof Turton, the interest shown in this technology is from both government and the private sector in North America, Africa, the Middle East, and Southeast Asia. A number of key decision-makers see the value of this technology in mitigating both financial and political risk. 

“They recognise that this pandemic is here to stay for a while, so they intend to get ahead of the curve, which is what the forensics service allows. An example is a condominium where a few hundred people live, but who are unable to use the facilities that they pay levies for. This service will enable all residents in a specific condominium to rebuild trust that they live in a ‘safe space’.” 

“For government, they recognise that this technology can feed data into their mapping systems. They refer to a ‘heat map’ that shows areas of viral activity and areas of relative safety. In one case, the focus is on monitoring each building in a city to identify which building is safe and which is a hot spot,” says Prof Turton. 

Next-generation science 
He explains that next-generation science refers to the algorithms used to extrapolate viral-load data to a larger cohort of people. The first-generation science was about the detection of the virus as a binary measurement: “Is the virus present, yes or no?”

“The current science can do this without a problem. Second-generation science is about how much virus is present? Is this more, or less, than we saw last week? If so, how much bigger or smaller is the signal? If so, can we mathematically calculate from a defined quantum of signal an accurate probability of the total viral load in the population being sampled?” 

“From this, can we say that 15% of the population is shedding virus (a number currently only possible from sewage surveillance) but personal testing shows us that only 5% of the population is positive? If so, we can then say that 10% of the population is both positive and asymptomatic. This has major implications for decision-makers, business owners, tourism operators, and governments who are losing revenue because of failing economies.” 
More importantly, says Prof Turton, is that this missing piece of data will become vital in testing for herd immunity, or the efficacy of a vaccine once available. 

The cost of the service 
By presenting a formal report to DWS, the team was able to get an accurate costing of the service. The cost of a single sewage sample, which can accurately monitor a geographically defined cohort (let’s say 100 000 people for the sake of illustration), is equivalent to 15–20 individual samples (nasal swabs, for example). “We can sample 100 000 people at the same cost as 15 can be sampled individually. More importantly, it is highly unlikely that any government in the world will ever reach anything more than 10% sampling at individual level. This tells us that while individual sampling might be very useful, it is logistically complex, and has a political risk when it cannot be rolled out across a large enough portion of society,” says Prof Turton.  

“The virus-risk forensic service that we have been developing can identify specific hot-spot areas, and those can be targeted for higher saturation coverage of individual testing. For example, in the DWS PoC, we identified one specific WWTW that is a definite hot spot, but another that has no viral signal at all. This means that those people living in the area with no viral signal are safe and do not need to be individually tested, but those in the hot spot need to be isolated and targeted for individual testing. More importantly, we can now say that the hot-spot area is likely to result in demand for medical services in a specific area, so planning can be done before the wave hits the hospital,” explains Prof Turton.   
With the submission of the formal report to government, the Business Water Chamber, and the Public Private Growth Initiative (PPGI), we can now announce a team to offer this virus-risk forensic service to any party with a need for this support in both the public and private sectors.

The team is:  
• Prof Anthony Turton – Centre for Environmental Management at the UFS, responsible for the conceptual design of the virus-risk forensic service. 

• Dr Mpafane Deyi – a graduate from the UFS and CEO of Amanzi-4-All, responsible for implementation of the service to both private and public sector partners.

• Dr Leon Geustyn – Director of Amanzi-4-All, responsible for the mathematical and technical aspects of the risk-based diagnostic service. 

• Dr Shaun Groenink – Director of GreenHill Laboratories, responsible for the laboratory support required.
• Dr Cara-Lesley Bartlett – Senior Scientist at GreenHill Laboratories.

• Mr Neil Madgwick – Director of Praecautio, responsible for the coordination of laboratories as the service grows across the African continent.

• Mr Kevin Lindsay – Director of Instru-Serve, responsible for the refinement of bulk sampling techniques and the supply chain from point of collection to the laboratories.
 

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept